Contents
Nr. 2 - 2. Quartal 2000

• HLA Incompatibility and Cold Ischemia Period as Risk Factors for Renal Allograft Survival
  U. Kuhlmann, R. Lenhard, G. Persijn, H. Lange

• Results and Surgical Aspects in Living Kidney Donation
  H. H. Wolters, T. Vowinkel, M. Schult, S. Heidenreich, T. Vogel, N. Senninger, K. H. Dietl

• Conversion of Basic Immunosuppressive Regimen to Mycophenolat Mofetil (MMF) or Tacrolimus (Tac) in Long-Term Renal Transplant Recipients
  K. Menzel, H. Sperschneider, H.-J. Gröne

• From the Double Drug Therapy to the ATG Bolus Prophylaxis in Kidney Transplant Recipients
  J. Kaden

• End-stage Hepato-renal Disease: Combined Liver- and Kidney Transplantation? Report on Experiences in Münster
  T. Vowinkel, H. H. Wolters, M. Schult, T. Vogel, S. Heidenreich, J. Menzel, S. Diederich, G. Schürmann, K. H. Dietl, N. Senninger

• Long-term Follow-up after Tacrolimus-based Dual or Quadruple Induction Therapy Following Orthotopic Liver Transplantation
  J. M. Langrehr, J. Klupp, U. Neumann, R. Neuhaus, R. Lohmann, C. Radtke, P. Neuhaus

• Immunosuppression in Living-related and Living-unrelated Liver Transplantation
  H. Janßen, M. Malagó, G. Testa, C. Valentin-Gamazo, M. Hertl, C. E. Broelsch

• Small Bowel Transplantation and Monocyte-/Macrophage-Procoagulantactivity
  M. J. Stangl, H. Mebert, M. Weiss, T. Fischer, D. Theodorou, C. Hammer, F. W. Schildberg

• I.V. Myocphenolate Mofetil (MMF) in the Prophylaxis of Acute GvHD in Stem Cell Transplant Recipients
  W. Willenbacher, M. Shipkowa, S. Günzelmann, N. Basasra, V. Armstrong,A. A. Fauser, M. G. Kiehl

PABST SCIENCE PUBLISHERS Lengerich, Berlin, Riga, Rom, Wien, Zagreb